5VM
5AM Venture Management Portfolio holdings
AUM
$260M
This Quarter Return
+15.25%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$484M
AUM Growth
+$484M
(+8.3%)
Cap. Flow
+$15.4M
Cap. Flow
% of AUM
3.19%
Top 10 Holdings %
Top 10 Hldgs %
68.13%
Holding
29
New
1
Increased
3
Reduced
4
Closed
1
Top Buys
| 1 |
ARTV
Artiva Biotherapeutics, Inc. Common Stock
ARTV
|
$36.4M |
| 2 |
EyePoint Pharmaceuticals
EYPT
|
$7.99M |
| 3 |
CNTA
Centessa Pharmaceuticals
CNTA
|
$640K |
| 4 |
Biohaven
BHVN
|
$450K |
Top Sells
| 1 |
Enliven Therapeutics
ELVN
|
$21.9M |
| 2 |
Q32 Bio
QTTB
|
$4.52M |
| 3 |
Cogent Biosciences
COGT
|
$2.47M |
| 4 |
Skye Bioscience
SKYE
|
$1.04M |
| 5 |
Dianthus Therapeutics
DNTH
|
$36.9K |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Mersana Therapeutics
MRSN
$36.5M
| $2.47M | 0.51% |
1,305,000
| – | – |
|
27
Zentalis Pharmaceuticals
ZNTL
$122M
| $1.8M | 0.37% |
490,000
| – | – |
|
28
Cidara Therapeutics
CDTX
$1.66B
| $610K | 0.13% |
56,725
| – | – |
|
|
29
Q32 Bio
QTTB
$20.9M
| – | – |
-251,994
| Closed | -$4.52M |
|